Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Abrams

Showing results (161-170 of 731) with videos related to

Pageof 74
Sort By:
Blood|May 22, 2023
New ASH initiatives to improve patient care in the long-overlooked sickle cell diseaseVenée N Tubman, Narla Mohandas, Charles S Abrams
Cancer Treatment and Research|February 20, 2007
NCI's cancer therapy evaluation program: a commitment to treatment trialsJeffrey S Abrams, Anthony Murgo, Michaele C Christian
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 27, 2018
Bias, Operational Bias, and Generalizability in Phase II/III TrialsBoris Freidlin, Edward L Korn, Jeffrey S Abrams
The American Surgeon|December 1, 1995
Pyloric duplications: review and case studyS Cooper, R S Abrams, R A Carbaugh
New Directions for Mental Health Services|March 1, 1984
The wilderness challenge: an adjunctive treatmentG G Neffinger, J W Schiff, S Abrams
The New England Journal of Medicine|March 30, 2012
Bevacizumab in ovarian cancerEdward L Korn, Boris Freidlin, Jeffrey S Abrams
Cancer|August 1, 1994
New chemotherapeutic agents for breast cancerJ S Abrams, T D Moore, M Friedman
Biochemistry|April 23, 1991
Folding changes in membrane-inserted diphtheria toxin that may play important roles in its translocationJ X Jiang, F S Abrams, E London
Oncology (Williston Park, N.Y.)|May 12, 2004
Clinical trials referral resource. Current phase III, NCI-supported, Cooperative Group Clinical Trials in breast cancerJeffrey S Abrams, Rebecca A Enos, Mason Schoenfeldt
Nucleic Acids Research|September 11, 1991
PCR assay for a polymorphic TaqI site in the human K-ras-2 gene on chromosome 12p (KRAS2)E S Abrams, T Shtatland, L S Lerman
Pageof 74

Showing results (161-170 of 731) with videos related to

Sort By:
Pageof 74
Blood|May 22, 2023
New ASH initiatives to improve patient care in the long-overlooked sickle cell diseaseVenée N Tubman, Narla Mohandas, Charles S Abrams
Cancer Treatment and Research|February 20, 2007
NCI's cancer therapy evaluation program: a commitment to treatment trialsJeffrey S Abrams, Anthony Murgo, Michaele C Christian
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 27, 2018
Bias, Operational Bias, and Generalizability in Phase II/III TrialsBoris Freidlin, Edward L Korn, Jeffrey S Abrams
The American Surgeon|December 1, 1995
Pyloric duplications: review and case studyS Cooper, R S Abrams, R A Carbaugh
New Directions for Mental Health Services|March 1, 1984
The wilderness challenge: an adjunctive treatmentG G Neffinger, J W Schiff, S Abrams
The New England Journal of Medicine|March 30, 2012
Bevacizumab in ovarian cancerEdward L Korn, Boris Freidlin, Jeffrey S Abrams
Cancer|August 1, 1994
New chemotherapeutic agents for breast cancerJ S Abrams, T D Moore, M Friedman
Biochemistry|April 23, 1991
Folding changes in membrane-inserted diphtheria toxin that may play important roles in its translocationJ X Jiang, F S Abrams, E London
Oncology (Williston Park, N.Y.)|May 12, 2004
Clinical trials referral resource. Current phase III, NCI-supported, Cooperative Group Clinical Trials in breast cancerJeffrey S Abrams, Rebecca A Enos, Mason Schoenfeldt
Nucleic Acids Research|September 11, 1991
PCR assay for a polymorphic TaqI site in the human K-ras-2 gene on chromosome 12p (KRAS2)E S Abrams, T Shtatland, L S Lerman
Pageof 74